RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals When will the FDA reclassify BPC 157 to Category 1 Octagon AI The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Peptide Reclassification 2026 Amanecia Health US FDA is expected to lift restriction on certain peptides, NYT reports Reuters